| Price Range 12mo avg: | $940K – $6.3M |
|---|---|
| $/sf 12mo avg: | $376 |
| CAP Rate 12mo avg: | 6.87% |
| NOI average: | $193,167 |
| Lease Terms: | 15yrs NN |
| Building Size avg: | 8,000 SF |
| Lot Size avg: | 0.75+/- acres |
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health management services. As of September 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,225 outpatient dialysis centers located in the United States serving approximately 177,000 patients. The company also operated 104 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.
DaVita—which is Italian for “giving life”—has more than 50,000 teammates (employees) around the nation working to provide superior patient care and exemplify the company’s Core Values
| S&P Credit Rating: | BB- |
|---|---|
| Moody’s Credit Rating: | Ba3 |
| Annual Revenue 2014: | $12.8B |
| Annual Revenue 2013: | $11.8B |
| Revenue Growth: | ↑ 8.13% from 2013 |
| Net Income | $723M |
| Units (Dec. 2014) | 2,179 |
| Average Units Volume: | $331856K |
Yahoo! Finance: DVA News Latest Financial News for DVA
-
The Biggest Loser: DaVita Dives
on September 22, 2017 at 8:37 pm
Today, it lead the list of losers in the S&P 500, falling 6.1% to close at $57.52 a share after the Southern Investigative Reporting Foundation issued a report today that questioned how much of the company’s annual operating profit depends on monies received from the American Kidney Fund, as well as the huge premiums it’s paid for some services. The SIRF said it began diving in to DaVita’s after CEO Chief Executive Kent Thiry sidestepped an analyst's question at its annual investor day meeting regarding the portion of revenue DaVita collects treating dialysis patients whose insurance premiums are paid by the AKF's health insurance payment program. Fresenius Medical (FMS) fell 1.5%, while American Renal Associates (ARA) dropped 6.3%. […]
-
DaVita's stock tumbles to lead S&P 500 losers after scathing SIRF report
on September 22, 2017 at 5:21 pm
Shares of DaVita Inc. tumbled 7.0% in midday trade Friday to pace the S&P 500 decliners, after a Southern Investigative Reporting Foundation (SIRF) report questioned how the medical care services provider ... […]
-
DaVita, Inc. breached its 50 day moving average in a Bullish Manner : DVA-US : September 19, 2017
on September 19, 2017 at 1:33 pm
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for DaVita, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...) […]
-
Warren Buffett's Portfolio Companies Buying Back Stock Most Aggressively
on September 15, 2017 at 11:13 pm
Buffett likes share repurchases at the right pric […]
-
DaVita's (DVA) Green Initiatives Win a Coveted Golden Reward
on September 14, 2017 at 2:00 pm
DaVita's (DVA) environment-friendly operations are likely to enhance the company's long-term sustainable growth. Also, strong patient services drive DaVita's success story. […]
NYSE: DVA
